Here are four things to know.
- 1.RespirTech develops electronic-pulsating vests for patients with respiratory diseases such as chronic obstructive respiratory disease and cystic fibrosis. The vests, which cost $12,000 to $15,000, help patients clear their lungs by regularly inflating and deflating to improve circulation.
- James Ehlen, MD, RespirTech’s CEO, expects Amsterdam-based Philips to significantly scale out the business, which is on track to earn $50 million in revenue this year.
- RespirTech employs 200 people, and Dr. Ehlen said a few administrative positions may be cut following the deal.
- The deal is expected to close within several months.
More articles on supply chain:
McKesson 2017 revenue up 4%: 5 things to know
What Trump’s budget proposal means for FDA funding
Baking soda shortage forces hospitals to postpone surgeries, treatments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
